Headache management

Reading File
Finding Sources
Searching PubMed

"headache" AND "management"

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
I now have comprehensive data from multiple authoritative sources. Let me compile the full answer.

Headache Management

A structured, evidence-based overview covering classification, acute treatment, prophylaxis, and special headache types.

1. Classification - Red Flags First

Before managing headache, exclude secondary (dangerous) causes. The key warning signs are:
  • "Thunderclap" - sudden, worst-ever headache (subarachnoid hemorrhage until proven otherwise)
  • New headache in age >50 (giant cell arteritis, mass lesion)
  • Fever + neck stiffness (meningitis)
  • Headache with focal neurologic signs or papilloedema
  • Progressive worsening over days/weeks
  • Headache in a cancer or immunocompromised patient
90% of patients presenting to primary care with headache have migraine. - Harrison's Principles of Internal Medicine 22E, 2025

2. Primary Headache Types & Their Management

A. Migraine

Acute (Abortive) Treatment
Step up based on attack severity:
Step 1 - Mild attacks:
  • Aspirin, acetaminophen, or NSAIDs (ibuprofen, naproxen)
  • Combination: acetaminophen + aspirin + caffeine (FDA-approved)
  • Add a dopamine antagonist (metoclopramide 10 mg, prochlorperazine 10 mg) if nausea is present - also enhances GI absorption
Step 2 - Moderate-to-severe attacks (after NSAID failure):
DrugRouteDose
SumatriptanPO50-100 mg
RizatriptanPO10 mg
EletriptanPO40 mg
AlmotriptanPO12.5 mg
ZolmitriptanPO/nasal2.5 mg / 5 mg nasal
SumatriptanSC6 mg (fastest onset)
SumatriptanNasal20 mg
Rimegepant (CGRP antagonist)PO75 mg
Ubrogepant (CGRP antagonist)PO50-100 mg
Lasmiditan (5-HT1F agonist)PO50-200 mg
Triptans are selective 5-HT1B/1D receptor agonists. Rizatriptan and eletriptan are the most efficacious on a population basis. Sumatriptan and zolmitriptan offer multiple formulations. - Harrison's
Triptan timing is key: Give oral/nasal forms at aura onset; SC at headache onset. Do NOT give during aura to prevent headache - they are ineffective in the aura phase but safe if given then.
Triptan contraindications: Ischemic heart disease, uncontrolled hypertension, basilar or hemiplegic migraine, concurrent MAOIs.
Special clinical situations (from Harrison's treatment table):
SituationPreferred Option
Early vomitingZolmitriptan 5 mg nasal / Sumatriptan 6 mg SC
Rapid onset headacheSC or nasal triptans / DHE IM
Headache recurrenceErgotamine 2 mg PR / Naratriptan 2.5 mg / Eletriptan 40 mg
Poor tolerance of acute therapyNaratriptan, Almotriptan, Rimegepant, neuromodulation
Menstrual migraine preventionFrovatriptan, Rimegepant, or estrogen patches during menses
Dihydroergotamine (DHE): 1 mg IV (over 3 min) or IM, or 2 mg nasal spray. Pretreat with antiemetic. Contraindicated in pregnancy, ischemic heart disease, within 24h of triptan use.
ED/Parenteral setting:
  • IV prochlorperazine 5-10 mg (superior to opioids in RCTs)
  • IV metoclopramide 10 mg
  • IV ketorolac 15-30 mg
  • IV mixture: prochlorperazine 5 mg + DHE 0.5 mg over 2 min (common protocol)
  • Dexamethasone 6-10 mg IV as adjunct to reduce recurrence
  • Magnesium sulfate 2 g IV over 30 min (nonvalidated)
  • Opioids: Only for severe infrequent headache unresponsive to other therapies; avoid routine use as they worsen long-term outcomes and decrease future triptan responsiveness
Tintinalli's Emergency Medicine, Table 165-7
Neuromodulation (non-pharmacologic acute options):
  • Single-pulse transcranial magnetic stimulation (sTMS) - FDA cleared
  • Noninvasive vagus nerve stimulator (nVNS) - FDA cleared
  • Remote electrical neuromodulation (arm device)
  • Transcutaneous supraorbital nerve stimulation

Migraine Prophylaxis (Preventive Treatment)
Indicated when: ≥4 headache days/month, attacks significantly impairing function, failure/contraindication to acute therapies, medication overuse headache risk, or patient preference.
Established preventive agents:
Drug ClassAgentsNotes
Beta-blockersPropranolol, metoprolol, timololFirst-line; avoid in asthma, depression
AnticonvulsantsTopiramate, valproateFDA-approved; valproate teratogenic
TCAsAmitriptylineAlso treats comorbid depression/sleep
Calcium channel blockersVerapamilMore evidence for cluster headache
CGRP monoclonal antibodiesErenumab, fremanezumab, galcanezumab, eptinezumabNew class; SC/IV monthly; very effective
CGRP receptor antagonistsRimegepant (also used acutely)Oral, twice-weekly for prevention
SupplementsMagnesium, riboflavin (B2), CoQ10, feverfewModest evidence, good safety

B. Tension-Type Headache (TTH)

Characteristics: Bilateral, pressing/tightening (non-pulsating), mild-to-moderate, no vomiting, no significant nausea, no aggravation by activity.
Acute treatment:
  • Simple analgesics: aspirin, acetaminophen, NSAIDs (first-line for episodic TTH)
  • More severe headaches may require prescription analgesics, but no specific preparation has proven superior
  • Avoid opioids and barbiturate-containing combinations due to dependence and medication overuse risk
Prevention/chronic TTH:
  • Amitriptyline (single bedtime dose) - treatment of choice when anxiety/depression comorbid
  • Some evidence for calcium channel blockers, phenelzine, cyproheptadine
  • Propranolol and ergotamine are ineffective unless migraine features co-exist
  • Biofeedback, relaxation techniques, massage for anxious/stressed patients
  • Medication overuse is a key concern - gradual analgesic withdrawal is essential in chronic daily headache
Adams and Victor's Principles of Neurology, 12th Ed.

C. Cluster Headache

Characteristics: Unilateral periorbital/temporal, excruciating (15-180 min), autonomic features (lacrimation, conjunctival injection, nasal congestion, ptosis), episodic or chronic, M > F.
Acute treatment:
  • 100% oxygen via mask for 10-15 min at attack onset (highly effective, no side effects)
  • Sumatriptan 6 mg SC or zolmitriptan 5 mg nasal spray
  • Intranasal lidocaine (adjunct)
  • Ergotamine 2 mg orally at bedtime (for predictable nocturnal attacks)
Preventive/transitional treatment:
  • Verapamil (up to 480 mg/d) - first-line; requires ECG monitoring in older patients
  • Prednisone 75 mg/d tapering over ~3 weeks (short-term bridge)
  • Lithium 600-900 mg/d (chronic cluster; monitor for toxicity)
  • Galcanezumab (anti-CGRP monoclonal antibody) - halved weekly cluster frequency in clinical trials
  • Topiramate, melatonin as alternatives
Adams and Victor's Principles of Neurology, 12th Ed.; Harrison's 22E

D. Trigeminal Autonomic Cephalalgias (TACs) Comparison

FeatureClusterParoxysmal HemicraniaSUNCT/SUNA
Duration15-180 min2-30 min5-240 sec
Frequency1-8/day1-20/day3-200/day
Abortive RxO2, sumatriptan SCIndomethacin (diagnostic)IV lidocaine
PreventionVerapamil, galcanezumabIndomethacinLamotrigine
Paroxysmal hemicrania: Complete, absolute response to indomethacin is pathognomonic - start at 25 mg TID, titrate to 75 mg TID.
SUNCT/SUNA: Best prevented with lamotrigine 200-400 mg/d. Topiramate and gabapentin are alternatives.
Hemicrania continua: Unilateral continuous pain + autonomic features; complete response to indomethacin is diagnostic and therapeutic.

E. Medication Overuse Headache (MOH)

  • Occurs when acute medications are used >10-15 days/month
  • Highest risk: opioids and barbiturates > triptans > NSAIDs
  • Treatment: gradual withdrawal of the offending medication (can be done abruptly for triptans/NSAIDs; slower for opioids/barbiturates)
  • Preventive therapy should be started during withdrawal
  • Multidisciplinary support improves outcomes

3. When to Refer

Per Harrison's 22E: Refer to a headache specialist when:
  • No clear diagnosis
  • Primary headache other than migraine or TTH
  • Unresponsive to two or more standard therapies for the diagnosed type
  • Any suspected secondary headache requiring specialist workup

Recent Evidence Note

A 2024 BMJ network meta-analysis (PMID 39293828) on acute migraine management confirmed triptans as effective first-line agents and provided comparative efficacy data across drug classes - consistent with current guideline recommendations.

Abdominal koch’s pain abdomen mana

Reading File
Finding Sources
Searching PubMed

"abdominal tuberculosis" AND management

Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Loading Image
Now I have all the data needed. Here is the comprehensive answer:

Abdominal Tuberculosis (Koch's) - Pain Abdomen Management


Overview

Abdominal TB (Koch's abdomen) refers to TB involvement of the gastrointestinal tract, peritoneum, mesenteric lymph nodes, and/or solid organs. The abdomen is involved in ~11% of extrapulmonary TB cases. 50-80% of abdominal TB patients have peritoneal involvement. - Bailey and Love's Short Practice of Surgery, 28th Ed.

Forms of Abdominal TB

FormFeatures
Intestinal TBTerminal ileum/ileocaecal region most common (75%), ulcerative/hypertrophic/ulcerohypertrophic
Tuberculous peritonitisWet ascitic type (90%), dry fibrotic type (rare)
Mesenteric lymphadenitisEnlarged nodes, central caseation - can be seen on CT
Solid organLiver, spleen involvement less common

Clinical Presentation - Pain Abdomen in Abdominal TB

Chronic/Subacute:

  • Abdominal pain - nonspecific, chronic; most common complaint (80-90% of patients)
  • Weight loss, evening fever, malaise, night sweats
  • Alternating diarrhoea and constipation
  • Palpable RIF mass in 25-50% (ileocaecal involvement)
  • Ascites and abdominal distension (peritoneal TB)
  • "Doughy feel" of abdomen on palpation - a classical sign

Acute (Emergency presentation):

  • Features of acute distal small bowel obstruction - colicky pain, abdominal distension, bilious/faeculent vomiting, absolute constipation
  • Rarely: peritonitis from perforation of a tuberculous ulcer
  • Acute-on-chronic: superimposed obstruction on longstanding disease
These patients are often extremely ill - dehydrated, malnourished, anaemic, often with active pulmonary TB. - Bailey & Love

Investigations

Bloods:
  • FBC - mild anaemia, normal or mildly elevated WBC
  • Raised ESR/CRP
  • LFTs (especially with hepatic involvement)
  • Urea and electrolytes (dehydration in obstruction)
Microbiological:
  • Sputum AFB smear and culture (even without pulmonary symptoms, CXR is essential)
  • IGRA (Interferon-Gamma Release Assay) - Quantiferon or T-SPOT
  • Ascitic fluid analysis: straw-coloured exudate, protein >25-30 g/L, WBC >500/mL with lymphocytes >40%, AFB smear often negative, culture takes 4-8 weeks
  • Adenosine deaminase (ADA) in ascitic fluid - high sensitivity and specificity for peritoneal TB
  • Xpert MTB/RIF assay (on tissue, stool, or fluid) - more sensitive than AFB smear (~65%)
  • Tissue biopsy: granulomas with caseation on histology (seen in 50-80% of cases)
Imaging:
  • Plain AXR in obstruction: dilated small bowel loops, valvulae conniventes (concertina effect), fluid levels, featureless ileum
  • CXR: pulmonary infiltrates/TB lesions (may be normal)
  • USS abdomen: ascites (may be loculated), lymphadenopathy, bowel wall thickening
  • CT abdomen: ileocaecal valve thickening, asymmetric bowel wall thickening, massive lymphadenopathy with central necrosis (characteristic), cecal contraction, Stierlin sign
  • Barium meal/small bowel follow-through: multiple ileal strictures, subhepatic caecum (caecum pulled up by fibrosis - pathognomonic), ileum entering caecum in a straight line from below (Figure 6.38)
Barium meal and follow-through showing ileal strictures with subhepatic caecum - a hallmark of intestinal TB
Barium follow-through showing ileal strictures with the caecum in a subhepatic position - Bailey & Love, 28th Ed.
Endoscopy:
  • Colonoscopy with biopsy from ileocaecal region - most useful diagnostic procedure
  • AFB staining, PCR, and culture on biopsy tissue (with drug sensitivity testing)
  • Wear isolation masks when performing
Laparoscopy: Tubercles on bowel serosa, multiple strictures, high caecum, caseous lymph nodes, ascites - useful when biopsy via colonoscopy is inconclusive

Management

A. General Supportive Measures (All Patients)

  1. Nutrition - correct malnutrition; nasogastric or parenteral nutrition if required
  2. Hydration/fluid resuscitation - IV fluids for dehydration, especially in obstruction
  3. NGT decompression - in obstruction/ileus
  4. Anaemia correction - transfusion if Hb critically low pre-operatively
  5. Notify public health authorities - TB is a reportable disease; contact tracing

B. Medical Management - Anti-TB Therapy (MAINSTAY)

Abdominal TB is treated identically to pulmonary TB with standard short-course chemotherapy. A high index of suspicion warrants starting empirical therapy even before culture results - clinical response often occurs within 2 weeks. However, masses, hyperplasia, and strictures respond more slowly.
Standard Regimen (Drug-Sensitive TB):
PhaseDurationDrugsAbbreviation
Intensive phase2 monthsIsoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E)2HRZE
Continuation phase4 monthsIsoniazid (H) + Rifampicin (R)4HR
Total6 months
For extrapulmonary TB including abdominal TB, a total duration of 12-18 months may be preferred in some guidelines/settings due to the depth of tissue penetration and risk of relapse. - Bailey & Love
Important notes:
  • Send drug sensitivity testing (DST) from cultures - MDR-TB may be more prevalent in abdominal than pulmonary TB
  • Add pyridoxine (Vitamin B6) 10-25 mg/day with isoniazid (prevents peripheral neuropathy)
  • In HIV co-infection, ART should be initiated; standard TB regimens are used but with close monitoring for drug interactions (rifampicin and antiretrovirals)
  • Adjunctive corticosteroids (prednisolone) may be considered in peritoneal TB with ascites to reduce inflammation and adhesion formation (though evidence is limited)
  • Engage a TB specialist for management guidance

C. Surgical Management

Surgery is reserved for complications - it is NOT the primary treatment.

Indications for Surgery:

IndicationNotes
Intestinal obstruction not responding to medical therapyMost common surgical indication
Intestinal perforationEmergency - peritoneal contamination
Intestinal hemorrhageUncontrolled bleeding
Abdominal abscessDrainage required
Diagnostic uncertaintyBiopsy when endoscopic diagnosis not possible
Fistula formationEntero-enteric or entero-cutaneous
Key principle: Many cases of intestinal obstruction from TB will respond to anti-TB treatment without surgery. Always give adequate medical therapy before deciding on surgical intervention. - Bailey & Love, Summary Box 65.6

Surgical Options (Elective / Post-Medical Treatment):

After completion of medical treatment, re-image the small bowel. If significant strictures remain causing subacute obstruction:
Surgical ProcedureIndication
Limited ileocolic resection + anastomosisTerminal ileal/ileocolic hyperplastic disease
StrictureplastySingle ileal stricture (bowel-conserving)
Bowel resectionMultiple closely placed strictures
Right hemicolectomyExtensive ileocolic disease precluding limited resection
Surgical principles are similar to Crohn's disease - resections should be kept as conservative as possible to prevent short bowel syndrome. - Bailey & Love, 28th Ed.

Emergency Surgery (Acute Obstruction/Perforation):

These patients present in extremis - dehydrated, malnourished, anaemic, often with active pulmonary TB.
Pre-operative resuscitation is mandatory:
  • IV fluids - vigorous fluid resuscitation
  • NGT decompression
  • Correct electrolytes
  • Blood transfusion if severely anaemic
  • Broad-spectrum antibiotics (for perforation/secondary peritonitis)
At laparotomy - minimum life-saving procedure:
  • Resection of the diseased segment + proximal ileostomy + distal ileal or colonic mucus fistula (preferred)
  • This avoids primary anastomosis, which has a high leak rate in the presence of active infection and poor general condition
  • One-stage resection and anastomosis is only performed if the patient's general condition permits (rare in the emergency setting)

Peritoneal TB - Specific Management

  • Primarily medical (anti-TB chemotherapy as above)
  • Therapeutic paracentesis for tense ascites causing respiratory compromise
  • Laparoscopy + peritoneal biopsy if diagnosis in doubt
  • Distinguish from peritoneal metastases (CT-guided biopsy or laparoscopy)
  • Intestinal obstruction in peritoneal TB (fibrous "dry" type - matted loops) may respond to anti-TB therapy + corticosteroids alone before considering surgery

TB vs Crohn's Disease - Differential Diagnosis Points

FeatureIntestinal TBCrohn's Disease
Ileocaecal valveIncompetent (both sides involved)Usually competent
Ulcer orientationTransverse, circumferentialLongitudinal (along bowel axis)
Lymph nodesLarge (>1 cm), hypodense (caseous)Small, non-necrotic
Stierlin signPresentAbsent
GranulomasCaseatingNon-caseating
AFB/PCRPositiveNegative

Summary Algorithm

Suspected Abdominal Koch's (Pain abdomen)
        ↓
Red flags? (Obstruction / Perforation / Haemorrhage)
        ↓                        ↓
      YES                       NO
        ↓                        ↓
Emergency resuscitation    Confirm diagnosis
  + surgery if required    (Colonoscopy + biopsy, CT, ADA)
                                  ↓
                        START ANTI-TB THERAPY
                        (2HRZE → 4HR, 6-18 months)
                                  ↓
                     Clinical response within 2 weeks?
                        ↓                    ↓
                       YES                  NO
                        ↓                    ↓
                  Continue ATT          Re-evaluate diagnosis
                        ↓             Consider MDR-TB / biopsy
              Post-treatment imaging
                        ↓
              Residual stricture/obstruction?
                        ↓
              ELECTIVE SURGERY
              (Strictureplasty / Limited resection)

Sources: Sleisenger & Fordtran's Gastrointestinal and Liver Disease; Bailey and Love's Short Practice of Surgery, 28th Ed.; Goldman-Cecil Medicine
Recent evidence note: A 2025 systematic review on abdominal TB in children (PMID 40533676) and a 2025 diagnostic evaluation and management review (PMID 40023548) confirm that standard 6-month HRZE/HR regimens remain the backbone of treatment, with surgical intervention reserved for complications unresponsive to medical therapy.

U/l limb swelling differentials

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive, high-quality data from multiple authoritative sources. Here is the complete structured answer:

Upper Limb (U/L) Swelling - Differential Diagnoses

A systematic approach organized by mechanism, from common to rare and must-not-miss.

Framework for Approaching Upper Limb Swelling

Ask these key questions first:
QuestionNarrows Towards
Unilateral or bilateral?Unilateral = local/structural; Bilateral = systemic
Pitting or non-pitting?Pitting = venous/cardiac/hypoalbuminaemia; Non-pitting = lymphedema/myxoedema
Acute or chronic onset?Acute = DVT, cellulitis, trauma; Chronic = lymphedema, tumour
Hot, red, tender?Infective/inflammatory
Associated neck/facial swelling?SVC syndrome
Recent surgery/malignancy?Lymphedema, DVT, tumour recurrence
Trauma/strenuous exercise?Paget-Schroetter, haematoma, compartment syndrome

Differentials - Organized by System


1. VASCULAR

Upper Extremity Deep Vein Thrombosis (UE-DVT) - MUST NOT MISS

  • Accounts for <5% of all DVTs but carries 10-15% risk of PE
  • Primary (Paget-Schroetter disease / Effort thrombosis): Axillary/subclavian vein thrombosis from repetitive strenuous arm activity in young, healthy, muscular individuals (weight-lifters, overhead athletes). Associated with thoracic outlet compression by cervical rib or first rib
  • Secondary: Indwelling venous catheter (most common cause), mediastinal tumours, malignancy, hypercoagulable states, congestive heart failure, nephrotic syndrome, tamoxifen use
Features: Unilateral arm pain, oedema, heaviness/fullness, cyanosis; visible superficial venous distension over arm, forearm, shoulder, anterior chest wall
Investigation: Duplex ultrasound (first-line); CT venography/MRA/phlebography; positional phlebography with arm abduction to 120° (to confirm thoracic outlet compression); CXR (cervical rib)
- Mulholland & Greenfield's Surgery, 7th Ed.; Symptom to Diagnosis, 4th Ed.

Superior Vena Cava (SVC) Syndrome - MUST NOT MISS

  • Obstruction of the SVC causes bilateral upper limb + face + neck oedema
  • Causes: >90% malignant - bronchogenic carcinoma (right lung most common), lymphoma, mediastinal metastases; Non-malignant: sclerosing mediastinitis, goitre, indwelling catheter/pacemaker thrombosis, syphilis, mediastinal haematoma
  • Features: Bilateral arm + face + neck swelling (worse in morning), JVD, dilated chest wall collaterals (caput medusae of chest), dyspnoea, headache, visual disturbance, Pemberton's sign (facial congestion on arm raising), hoarseness, dysphagia
  • A neurological/oncological emergency if cerebral oedema develops
- Pye's Surgical Handicraft, 22nd Ed.

Subclavian Artery Aneurysm / Arteriovenous Fistula

  • Pulsatile swelling if aneurysm; thrill/bruit with AV fistula
  • May follow trauma, thoracic outlet compression, or iatrogenic injury
  • Post-traumatic AV fistulae cause distal venous hypertension and limb swelling

Venous Insufficiency / Post-Thrombotic Syndrome

  • Chronic oedema after previous axillary/subclavian DVT
  • Venous hypertension leads to persistent limb swelling and skin changes

2. LYMPHATIC

Secondary Lymphedema (Most Common Overall Cause)

  • Breast cancer-related lymphedema (BCRL): Most common cause of upper extremity lymphedema
    • Follows axillary lymph node dissection + mastectomy + radiotherapy
    • Risk factors: high number of nodes dissected, positive nodes, higher BMI, inactive lifestyle, radiation therapy
    • Presents as chronic non-pitting oedema, typically starting in the upper arm/humeral region, spreading to shoulder and forearm
    • Cellulitis of the ipsilateral arm is a frequent complication (non-group A haemolytic Streptococcus)
  • Other causes of secondary lymphedema: other malignancies with axillary/mediastinal nodal involvement, filariasis (Wuchereria bancrofti), post-infective (recurrent cellulitis), post-radiation, trauma

Primary Lymphedema

  • Extremely rare in the upper limb
  • Congenital (Milroy's-like), lymphedema praecox, lymphedema tarda
  • Due to aplasia/hypoplasia/dysfunction of lymphatics
Stewart-Treves Syndrome: Angiosarcoma (bluish/reddish nodules) arising in chronic post-mastectomy lymphedema - rare but important complication
- Sabiston Textbook of Surgery; Andrews' Diseases of the Skin

3. INFECTIVE / INFLAMMATORY

Cellulitis

  • Infection of deep dermis and subcutaneous tissue
  • Presents as: diffuse non-palpable erythema with indistinct margins, generalised swelling, warmth, tenderness; lymphangitis (red streaks); tender regional adenopathy
  • Organisms: S. aureus and Group A Streptococcus most common; MRSA in injection drug users, recurrent cases, abscess formation
  • Risk factors: Underlying lymphedema or venous insufficiency, prior breast cancer treatment, eczema, tinea pedis (entry site identified in 77%), trauma, obesity, injection drug use
  • Systemic features (high fever, rigors) suggest bacteraemia or necrotizing fasciitis

Erysipelas

  • Superficial cellulitis with prominent lymphatic involvement
  • Sharply demarcated raised erythematous border (distinguishes from cellulitis)
  • Sudden onset fever (85%), rapidly spreading (2-10 cm/day)
  • Risk factors: lymphedema, tinea pedis (portal of entry)

Necrotizing Fasciitis - MUST NOT MISS

  • Deep infection tracking along fascial planes; disproportionate pain, woody oedema, systemic sepsis, skin necrosis/bullae/crepitus
  • Surgical emergency

Septic Arthritis / Osteomyelitis

  • Localised joint or bone pain, swelling, restricted movement, fever

Lymphadenitis (Axillary)

  • Localised axillary swelling/tenderness; may cause mild arm swelling due to lymphatic obstruction
  • Causes: bacterial (cat-scratch disease - Bartonella henselae, staphylococcal, streptococcal), viral (EBV, HIV)

Abscess

  • Fluctuant, tender, localised; may track to produce diffuse swelling

4. MUSCULOSKELETAL / TRAUMATIC

Fracture

  • History of trauma; deformity, crepitus, point tenderness; confirmed on X-ray

Haematoma

  • Trauma, anticoagulation, or spontaneous (haemophilia); tense, bruised swelling

Compartment Syndrome - MUST NOT MISS

  • 6 Ps: Pain (disproportionate, especially on passive stretch), Pressure (tight compartment), Paraesthesia, Paralysis (late), Pallor, Pulselessness (late)
  • Causes: fracture, crush injury, reperfusion, tight cast/bandage
  • Surgical emergency (fasciotomy)

Muscle Tear / Haematoma

  • Acute onset with exertion or trauma; ecchymosis, fusiform swelling

Tendon Rupture (Biceps Tendon)

  • "Popeye" sign (retracted biceps muscle belly), sudden pain/swelling in antecubital fossa

Osteosarcoma / Bone Tumour

  • Gradually enlarging, hard, fixed swelling over long bone; night pain, systemic symptoms

5. NEOPLASTIC / COMPRESSIVE

Primary Tumours

  • Soft tissue sarcoma: slow-growing, deep, firm mass
  • Lipoma: soft, lobulated, non-tender (most common benign soft tissue tumour)
  • Ganglion cyst: tense, transilluminant, arising near joints/tendons (wrist most common)
  • Haemangioma/Vascular malformations

Secondary / Metastatic Disease

  • Direct infiltration or nodal involvement from breast, lung, melanoma

Axillary Lymphadenopathy

  • Causes arm swelling by proximal lymphatic/venous obstruction
  • Causes: metastatic carcinoma (breast most common), lymphoma, leukemia, melanoma, sarcoidosis, infective

Thoracic Outlet Syndrome (TOS)

  • Compression of neurovascular structures at the thoracic outlet (between clavicle/first rib) by cervical rib, fibrous band, or hypertrophied scalene muscles
  • Neurogenic (most common): paraesthesia, weakness
  • Venous (Paget-Schroetter): arm swelling, cyanosis (see DVT above)
  • Arterial (rarest): pallor, cold hand, digital ischaemia

6. SYSTEMIC / GENERALISED CAUSES (Bilateral > Unilateral)

CauseKey Features
Congestive cardiac failureBilateral pitting oedema, JVP raised, dyspnoea
Hypoalbuminaemia (nephrotic, cirrhosis, malnutrition)Bilateral pitting, low albumin
Hypothyroidism (myxoedema)Non-pitting, periorbital puffiness, bradycardia, cold intolerance
Renal failureBilateral pitting oedema, uraemia
Anaphylaxis / AngioedemaRapid onset, urticaria, laryngeal oedema, hypotension
LipoedemaBilateral fat deposition (spares hands/feet), not true oedema

7. DRUG-INDUCED

DrugMechanism
Calcium channel blockers (amlodipine)Arteriolar dilatation → dependent oedema
NSAIDsSodium/water retention
CorticosteroidsFluid retention
TamoxifenDVT risk (relative risk ~3x)
IV contrast / drug reactionsLocal/allergic
Chemotherapy agentsVenous fibrosis / lymphatic damage

Summary Table - Key Differentials

DiagnosisOnsetLateralityPittingKey Feature
UE-DVTAcuteUnilateralYesRisk factors, collateral veins
CellulitisAcuteUnilateralYesHot, red, tender, +/- fever
Compartment syndromeAcuteUnilateralNoDisproportionate pain, tight
Lymphedema (post-mastectomy)Subacute/chronicUnilateralNo (late)H/o breast cancer treatment
SVC syndromeSubacuteBilateral (+ face/neck)YesCollaterals, dyspnoea
Paget-Schroetter (DVT)AcuteUnilateralYesYoung athlete, exertion
Soft tissue tumourChronicUnilateralNoFirm, painless mass
AngioedemaMinutesBilateral or focalNoAllergic trigger, urticaria
Fracture/haematomaAcute post-traumaUnilateralVariableHistory of trauma

Always think about DVT in a patient with unilateral limb swelling. - Symptom to Diagnosis: An Evidence-Based Guide, 4th Ed.
Sources: Bailey & Love's Short Practice of Surgery 28th Ed.; Mulholland & Greenfield's Surgery 7th Ed.; Symptom to Diagnosis 4th Ed.; Sabiston Textbook of Surgery; Andrews' Diseases of the Skin; Pye's Surgical Handicraft 22nd Ed.

u/l unilateral swelling differentials

Asking for Preferences
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I have all the data needed from authoritative sources plus the comprehensive foundation from the previous response. Here is the focused, unilateral-specific answer:

Unilateral Upper Limb Swelling - Differentials

Unilateral swelling immediately points away from systemic causes (cardiac failure, hypoalbuminaemia, bilateral lymphedema) and towards local structural, vascular, infective, inflammatory, or neoplastic pathology.

Surgical Sieve - VITAMINC Framework

CategoryCondition
VascularUE-DVT, Superficial thrombophlebitis, AV fistula, Venous injury
InfectiveCellulitis, Erysipelas, Necrotizing fasciitis, Abscess, Lymphangitis
TraumaticFracture, Haematoma, Compartment syndrome, Muscle tear, Dislocation
Autoimmune / InflammatoryGout, Pseudogout, Septic arthritis, CRPS, Rheumatoid flare, DVT-related
MetabolicHypothyroidism (myxoedema - rare, usually bilateral)
Iatrogenic / DrugIV extravasation, PICC line thrombosis, Drug reaction
NeoplasticSoft tissue sarcoma, Lipoma, Ganglion, Axillary nodal mass, Metastasis
Congenital / LymphaticPrimary lymphedema, Thoracic outlet syndrome (venous)

Differentials in Order of Likelihood

MUST NOT MISS (Urgent/Emergency)


1. Upper Extremity DVT (UE-DVT)

The single most important diagnosis to exclude in any unilateral arm swelling.
  • Accounts for ~5% of all DVTs; carries up to 33% risk of PE
  • Primary - Paget-Schroetter (Effort) Thrombosis:
    • Young, healthy, dominant arm of athletes (swimmers, weight-lifters, overhead workers)
    • Repetitive arm motion + anatomical compression at thoracic outlet (cervical rib, myofascial bands, hypertrophied scalenes) → subclavian vein DVT
    • Classic: sudden onset arm swelling after strenuous exertion
  • Secondary (>90% of cases):
    • Indwelling central venous catheter / PICC line / pacemaker lead (most common cause)
    • Malignancy (occult or known) - idiopathic UE-DVT warrants cancer workup
    • Hypercoagulable state (thrombophilia, OCP, malignancy)
    • Mediastinal mass compressing subclavian vein
Clinical features: Unilateral swelling, pain, heaviness/fullness, erythema, palpable venous cord; dilated superficial collateral veins over arm, shoulder, anterior chest wall; cyanosis
Investigation: Duplex USS (first-line; may be limited at mid-subclavian due to clavicle) → Venography / MR venography if USS inconclusive; CXR (cervical rib); positional phlebography (arm at 120° abduction) to confirm thoracic outlet compression
Treatment: Anticoagulation (DOAC or LMWH/warfarin) × 3 months; Paget-Schroetter: thrombolysis + thoracic outlet decompression (first rib resection ± scalenectomy) + possible venous reconstruction
- Sabiston Textbook of Surgery; Rosen's Emergency Medicine; Mulholland & Greenfield's Surgery

2. Compartment Syndrome

  • Emergency requiring fasciotomy within hours to prevent permanent muscle/nerve damage
  • Causes: fracture (especially supracondylar in children, radius/ulna), crush injury, tight plaster/bandage, reperfusion after ischaemia, burns, snake bite
  • 6 Ps: Pain (disproportionate, worst on passive stretch of fingers - earliest sign), Pressure (tight, tense compartment), Paraesthesia (tingling/numbness), Paralysis (late), Pallor, Pulselessness (very late - do not wait for this)
  • Compartment pressure >30 mmHg (or within 30 mmHg of diastolic BP) = fasciotomy threshold

3. Necrotizing Fasciitis

  • Deep-tissue infection tracking rapidly along fascial planes
  • Clues: pain disproportionate to appearance, woody indurated oedema, skin crepitus (gas-forming organisms), haemorrhagic bullae, rapid systemic sepsis
  • LRINEC score aids diagnosis (CRP, WBC, Na, creatinine, glucose, Hb)
  • Emergency surgical debridement

COMMON


4. Cellulitis

  • Infection of deep dermis and subcutaneous tissue
  • Features: Diffuse non-palpable erythema with indistinct margins, generalised swelling, warmth, tenderness; lymphangitis (red streaking proximally); tender axillary adenopathy
  • Organisms: S. aureus, Group A Streptococcus; MRSA in injection drug users, abscess-associated
  • Portal of entry identified in 77% - skin break, wound, eczema, tinea, bite
  • Risk factors: Underlying lymphedema (post-mastectomy patients especially), venous insufficiency, obesity, eczema, injection drug use, IV catheter sites
  • Fever/rigors → bacteraemia or necrotizing fasciitis; do not miss

5. Erysipelas

  • Superficial cellulitis with prominent lymphatic involvement
  • Sharply demarcated raised, bright-red, indurated border (distinguishes from cellulitis)
  • Abrupt onset, high fever (85%), rapid spread (2-10 cm/day)
  • Organism: Group A Streptococcus (almost exclusively)
  • Risk factors: same as cellulitis; lymphedema + tinea pedis are strongest risk factors

6. Post-Mastectomy / Secondary Lymphedema

  • Most common cause of chronic unilateral upper limb swelling in women
  • Follows axillary lymph node dissection + mastectomy + radiotherapy for breast cancer
  • Onset: weeks to years after treatment
  • Features: Gradually progressive non-pitting oedema, starts at upper arm (humeral region), spreads to shoulder and forearm; skin thickening and fibrosis (late); recurrent cellulitis episodes
  • Risk factors: extensive axillary dissection, positive nodes, radiotherapy, high BMI, inactivity
  • Stewart-Treves syndrome: Angiosarcoma (bluish/reddish nodules) arising in chronic lymphedema - rare but fatal complication
  • Other causes of secondary lymphedema: filariasis, any axillary/mediastinal malignancy, recurrent cellulitis, trauma

7. Fracture / Dislocation

  • History of trauma; focal point tenderness, deformity, crepitus, abnormal ROM
  • Any bone in the upper limb; distal radius most common in adults (Colles')
  • Pathological fracture: fracture through bone metastasis/cyst - may be spontaneous or minimal trauma

8. Haematoma

  • Soft tissue bleeding following trauma, anticoagulation, or spontaneous (haemophilia, thrombocytopenia)
  • Tense, bruised swelling; ecchymosis may track distally; fluctuant if large
  • Can mimic DVT clinically; USS distinguishes

LESS COMMON BUT IMPORTANT


9. Superficial Thrombophlebitis (SVT)

  • Thrombosis of a superficial vein
  • Features: Linear, erythematous, tender, swollen cord along vein; localised rather than diffuse swelling
  • Causes: IV cannula/catheter (commonest), varicose veins, trauma, thrombophilia, malignancy
  • Trousseau's sign - migratory thrombophlebitis associated with occult malignancy (especially pancreatic tail)
  • 3-15% have concurrent DVT - duplex USS if in doubt

10. Septic Arthritis

  • Acute, hot, swollen, painful joint - severely restricted range of motion
  • Patient toxic/febrile; child with reluctant limb use
  • Organisms: S. aureus (most common), Gonococcus in young adults, Gram-negatives in immunocompromised
  • Joint aspiration is diagnostic and therapeutic
  • Osteomyelitis can co-exist or present similarly

11. Gout / Pseudogout

  • Crystal arthropathy causing acute monoarthritis
  • Wrist, MCP joints (gout); wrist, elbow (pseudogout/CPPD)
  • Acutely red, hot, exquisitely tender joint with periarticular swelling
  • Urate crystals (negatively birefringent) vs. calcium pyrophosphate (weakly positively birefringent) on joint aspirate
  • Elevated serum urate (but may be normal during acute attack)

12. Complex Regional Pain Syndrome (CRPS) - Reflex Sympathetic Dystrophy

  • Follows injury, surgery, or stroke; often disproportionate to initial injury
  • Features: Burning pain, allodynia, diffuse oedema, skin colour/temperature changes (warm/red early → cool/cyanotic late), trophic changes (shiny skin, hair/nail changes), hyperhidrosis
  • Sudeck's atrophy: osteoporosis on X-ray
  • CRPS Type 1 (no nerve injury) vs. Type 2 (with nerve injury = causalgia)

13. Soft Tissue Tumours

  • Lipoma: Soft, lobulated, compressible, non-tender; slowly enlarging; most common benign soft tissue tumour
  • Ganglion cyst: Tense, transilluminant; arising near joint capsule/tendon sheath; wrist most common
  • Soft tissue sarcoma: Deep, firm, >5 cm, painless, rapidly growing - refer urgently (2-week wait rule)
  • Haemangioma/Vascular malformation: Soft, compressible, bluish; may enlarge on dependency

14. Axillary Lymphadenopathy

  • Enlarged axillary nodes causing proximal lymphatic/venous obstruction → arm swelling
  • Causes: breast cancer metastasis, lymphoma/leukaemia, melanoma, sarcoidosis, reactive (infection)
  • Associated: palpable axillary mass, non-tender (malignant) vs. tender (infective)

15. Thoracic Outlet Syndrome (Venous Form)

  • Compression at the thoracic outlet by cervical rib, first rib, or scalene muscles
  • Venous TOS = subclavian vein compression → UE-DVT (Paget-Schroetter) or intermittent obstruction
  • Arterial TOS: pallor, cold digits, emboli, digital ischaemia
  • Neurogenic TOS (most common form): paraesthesia in ulnar distribution, weakness - not usually swelling

16. IV Extravasation / Infiltration

  • Leakage of IV fluid or chemotherapy agents into surrounding tissue
  • Localised swelling, pain, blanching at cannula site; blistering/necrosis with vesicant agents

17. Insect Bite / Envenomation / Anaphylaxis

  • Rapid onset localised swelling at bite site ± urticaria; anaphylaxis causes rapid diffuse swelling
  • Snake bite: fang marks, progressive oedema, coagulopathy
  • Angioedema (bradykinin-mediated - ACE inhibitor, hereditary): rapid onset non-pitting, non-prurigenic swelling

Clinical Decision Framework

UNILATERAL ARM SWELLING
         |
    ┌────┴─────┐
  ACUTE      CHRONIC
    |              |
  ┌─┴──┐      ┌──┴───┐
Hot/red? Pain/trauma?  Non-pitting?  Post-mastectomy?
  |         |          |                  |
Cellulitis  Fracture  Lymphedema    BCRL/lymphedema
Erysipelas  Haematoma  CRPS          Stewart-Treves
NF         Compartment
           syndrome
    |
History of catheter/
indwelling device/
malignancy/exertion?
    |
   DVT

Key Distinguishing Features at a Glance

DiagnosisOnsetSkin ChangesPainFeverKey Clue
UE-DVTAcuteErythema/cyanosisModerateNoCatheter / athlete / collaterals
CellulitisAcuteHot, red, indistinct borderYesOftenEntry site, lymphangitis
ErysipelasAcuteRaised, sharp borderYesHighStrep, face/limb
Necrotizing fasciitisAcuteBullae, crepitus, necrosisExtremeHigh, septicPain >> appearance
Compartment syndromeAcuteTense, tightExtreme (passive stretch)NoPost-fracture/trauma
LymphedemaChronicNon-pitting, skin thickeningNoNoPost-mastectomy, non-pitting
HaematomaAcute post-traumaBruising, ecchymosisYesNoTrauma/anticoagulation
GoutAcuteRed, periarticularExtremeSometimesJoint-centred, urate
CRPSSubacuteShiny, colour changeBurningNoAllodynia, post-injury
Soft tissue tumourChronicNormalNoNoMass, progressive
SVTAcuteLinear erythemaLocalisedLowPalpable cord along vein

Sources: Sabiston Textbook of Surgery; Rosen's Emergency Medicine; Mulholland & Greenfield's Surgery 7th Ed.; Symptom to Diagnosis 4th Ed.; Bailey & Love's Short Practice of Surgery 28th Ed.

Upper limb unilateral swelling differentials

This was already covered in full detail in the previous response. Here is a clean, complete summary:

Upper Limb Unilateral Swelling - Differentials


Key Discriminating Questions

QuestionPoints Towards
Acute vs chronic onset?Acute = DVT, cellulitis, trauma; Chronic = lymphedema, tumour
Hot + red + tender?Infective/inflammatory
After trauma/exertion?Fracture, haematoma, Paget-Schroetter DVT
Indwelling catheter/PICC/pacemaker?Secondary UE-DVT
Previous breast cancer treatment?Post-mastectomy lymphedema
Pain disproportionate to appearance?Compartment syndrome, necrotizing fasciitis
Palpable cord along vein?Superficial thrombophlebitis
Joint-centred swelling?Septic arthritis, gout/pseudogout
Firm/painless/progressive mass?Soft tissue tumour
Visible collateral veins on chest/shoulder?UE-DVT, SVC obstruction

Differentials by Category

1. Vascular

ConditionKey Features
Upper Extremity DVT (MUST NOT MISS)Arm pain, swelling, heaviness; dilated collaterals on chest/shoulder; risk: catheter, athlete (Paget-Schroetter), malignancy, thrombophilia; PE risk up to 33%
Paget-Schroetter syndromeYoung athlete, dominant arm, strenuous repetitive exertion; subclavian/axillary vein thrombosis from thoracic outlet compression (cervical rib, scalenes)
Superficial thrombophlebitisLinear tender erythematous cord along superficial vein; IV cannula site, varicose veins, thrombophilia; Trousseau's migratory = occult malignancy
AV fistulaPulsatile/throbbing swelling, thrill, bruit; post-traumatic or iatrogenic
Venous injury / post-traumaticHistory of trauma or surgery; venous hypertension in drained territory

2. Infective / Inflammatory

ConditionKey Features
CellulitisAcute diffuse erythema with indistinct borders, warmth, tenderness; entry site (wound, eczema, tinea) in 77%; organisms: S. aureus, GAS; risk: lymphedema, venous insufficiency
ErysipelasSuperficial, sharply demarcated raised red plaque; high fever; GAS; spreads 2-10 cm/day
Necrotizing fasciitis (MUST NOT MISS)Pain >> appearance; woody oedema; bullae, crepitus, skin necrosis; rapid sepsis; surgical emergency
AbscessFluctuant, tender, localised; MRSA in injection drug users
Septic arthritisAcutely red, hot, tender joint; severely restricted ROM; fever; joint aspiration diagnostic
OsteomyelitisDeep bone pain, local tenderness, fever; MRI is gold standard
LymphangitisRed streaking proximally from portal of entry; regional adenopathy

3. Traumatic / Orthopaedic

ConditionKey Features
Compartment syndrome (MUST NOT MISS)6 Ps: Pain (passive stretch - earliest), Pressure, Paraesthesia, Paralysis, Pallor, Pulselessness (late); post-fracture/crush; pressure >30 mmHg = fasciotomy
FractureTrauma history; point tenderness, deformity, crepitus, abnormal movement; pathological = through metastasis/cyst
HaematomaTrauma/anticoagulation; tense, bruised, ecchymosis tracking distally
Muscle tear (biceps/triceps)Acute exertion; "Popeye" sign (biceps); fusiform swelling, ecchymosis
DislocationDeformity + restricted ROM; neurovascular compromise
Ligament/tendon injuryFocal periarticular swelling, effusion, functional loss

4. Lymphatic

ConditionKey Features
Secondary lymphedema - BCRLMost common cause of chronic unilateral UL swelling; follows axillary node dissection + mastectomy + radiotherapy; non-pitting, starts at upper arm, spreads distally; recurrent cellulitis
Secondary lymphedema - otherFilariasis (Wuchereria bancrofti), other malignancy with axillary/mediastinal nodal involvement, post-radiotherapy, recurrent infections
Primary lymphedemaVery rare in upper limb; congenital or early-onset aplasia/hypoplasia of lymphatics
Stewart-Treves syndromeAngiosarcoma (blue-red nodules) arising in chronic post-mastectomy lymphedema - rare but aggressive

5. Neoplastic

ConditionKey Features
LipomaSoft, lobulated, compressible, non-tender, freely mobile; most common benign soft tissue tumour
Ganglion cystTense, transilluminant; arises from joint capsule/tendon sheath; wrist most common
Soft tissue sarcomaDeep, firm, >5 cm, painless, rapidly growing - urgent referral (2-week rule)
Haemangioma / Vascular malformationSoft, compressible, bluish; enlarges on dependency
Axillary lymphadenopathyPalpable nodal mass causing lymphatic/venous obstruction; breast cancer metastasis, lymphoma, melanoma
Bone tumour / metastasisPain at rest/night, bony swelling, pathological fracture

6. Neurological / Autonomic

ConditionKey Features
CRPS (Complex Regional Pain Syndrome)Post-injury or post-surgical; burning pain, allodynia, diffuse non-pitting oedema; skin colour/temperature changes (warm/red early → cold/dusky late); trophic changes; Sudeck's atrophy on X-ray

7. Iatrogenic / Drug

ConditionKey Features
IV extravasationLocalised swelling at cannula site; blistering/necrosis with vesicant chemotherapy agents
PICC/central line thrombosisCatheter-associated UE-DVT (>90% of secondary UE-DVT)
Drug reaction / angioedemaACE inhibitor-induced or hereditary; rapid-onset non-pitting, non-pruritic swelling; bradykinin-mediated
Calcium channel blocker oedemaUsually bilateral but can be asymmetric

8. Inflammatory / Rheumatological

ConditionKey Features
GoutAcute monoarthritis; wrist, MCPs; exquisitely tender; negatively birefringent urate crystals
Pseudogout (CPPD)Wrist, elbow; weakly positively birefringent calcium pyrophosphate crystals
Rheumatoid arthritis flareSymmetric MCP/PIP joint swelling usually; can be asymmetric in early disease
Reactive arthritisFollows infection; asymmetric oligoarthritis; urethritis + conjunctivitis (Reiter's triad)
Insect bite / envenomationRapid localised oedema; fang marks (snake bite); urticaria (allergic)

Priority Summary - By Urgency

PriorityDiagnosisWhy Urgent
🔴 EmergencyCompartment syndromePermanent ischaemic contracture within hours
🔴 EmergencyNecrotizing fasciitisFatal if surgical debridement delayed
🔴 EmergencySeptic arthritisJoint destruction within 24-48 hours
🟠 UrgentUE-DVTPE risk up to 33%
🟠 UrgentAcute limb ischaemia (arterial)Limb loss within 6 hours
🟡 Same-dayCellulitis with systemic featuresBacteraemia, sepsis
🟡 Same-dayFracture with neurovascular compromiseNerve/vessel injury
🟢 RoutineLymphedema, lipoma, ganglion, CRPSNon-immediately life/limb threatening

Investigation Pathway

Unilateral Upper Limb Swelling
           |
    Trauma history?
    YES → X-ray ± CT
    NO  ↓
    Hot/red/fever?
    YES → Cellulitis vs. NF vs. septic arthritis
          (bloods, cultures, LRINEC score, USS/MRI)
    NO  ↓
    Risk factors for DVT / catheter in situ?
    YES → Duplex USS → Venography/MRV if inconclusive
    NO  ↓
    Chronic, non-pitting, post-mastectomy?
    YES → Lymphedema (clinical diagnosis ± lymphoscintigraphy)
    NO  ↓
    Palpable mass?
    YES → USS ± MRI ± biopsy (sarcoma protocol if >5cm/deep)
    NO  ↓
    Post-injury, burning pain, allodynia?
    YES → CRPS (clinical diagnosis, 3-phase bone scan)

Sources: Sabiston Textbook of Surgery; Rosen's Emergency Medicine; Mulholland & Greenfield's Surgery, 7th Ed.; Symptom to Diagnosis, 4th Ed.; Bailey & Love's Short Practice of Surgery, 28th Ed.

Treatment for pain abdomen in k:co of abdominal koch

Finding Sources
Finding Sources
Searching PubMed

"abdominal tuberculosis" AND "pain" AND management

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
I now have all the data needed. Here is the focused, clinically structured answer:

Treatment of Pain Abdomen in a K/C of Abdominal Koch's (Abdominal TB)

A patient with a known case of abdominal TB presenting with pain abdomen requires a stepwise assessment - is this pain from active disease, a complication, or a superimposed problem?

Step 1 - Categorize the Pain

CategoryClinical ScenarioUrgency
Active disease painDull, colicky, chronic - disease not yet controlled or early treatmentRoutine
Subacute obstructionIntermittent colicky pain, distension, on-treatmentUrgent
Acute obstructionSevere colicky pain, distension, vomiting, absolute constipationEmergency
Perforation / PeritonitisSudden severe pain, guarding, rigidity, board-like abdomenEmergency
AbscessLocalised pain, fever, tender massUrgent
Ascites painDull ache, distension, shifting dullnessRoutine
Perforation can occur even during anti-TB treatment - always exclude in a k/c of abdominal Koch's with acute pain. - Sleisenger & Fordtran's GI and Liver Disease

Step 2 - Immediate Assessment

A. History

  • Is the patient currently on ATT? For how long? Adherent?
  • Character of pain: colicky (obstruction) vs. constant (peritonitis/abscess) vs. dull chronic (active disease)
  • Vomiting - bilious/faeculent (obstruction)?
  • Last bowel opening / flatus (absolute constipation = obstruction)
  • Fever, rigors (superimposed infection, abscess, perforation)
  • Weight trend (improving/worsening on ATT)

B. Examination

  • Vitals: Tachycardia, hypotension, fever - sepsis, perforation
  • Abdomen:
    • Distension + tinkling/absent bowel sounds → obstruction
    • Guarding + rigidity + rebound → peritonitis/perforation
    • Doughy feel + localised ascites → active peritoneal TB
    • RIF mass → ileocaecal disease, abscess
    • Shifting dullness → ascites

C. Investigations

  • Bloods: CBC, CRP/ESR, LFTs (ATT hepatotoxicity), urea/electrolytes (dehydration)
  • Plain AXR: Dilated small bowel loops with fluid levels (obstruction); free gas under diaphragm (perforation)
  • USS abdomen: Ascites (loculated vs free), abscess, lymph nodes, bowel wall thickening
  • CT abdomen (gold standard): Obstruction site and level, perforation, abscess, lymphadenopathy with central necrosis, disease extent
  • LFTs - check before continuing ATT if hepatotoxicity suspected

Step 3 - Treatment Based on Scenario


A. Chronic/Active Disease Pain (No Complication)

Pain is from the disease itself - inflammation, ulceration, partial obstruction, mesenteric lymphadenopathy, peritonitis.

1. Continue/Optimise Anti-TB Therapy (ATT) - THE CORNERSTONE

Standard first-line regimen:
PhaseDurationDrugsShort form
Intensive phase2 monthsIsoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E)2HRZE
Continuation phase4-10 monthsIsoniazid (H) + Rifampicin (R)4-10HR
Total duration 6-12 months standard; up to 12-18 months preferred for abdominal TB in many guidelines. Patients should be under combined physician and surgeon care. - Bailey & Love, 28th Ed.
Add always:
  • Pyridoxine (Vitamin B6) 10-25 mg/day with isoniazid (prevents peripheral neuropathy)
Monitor for ATT side effects as a cause of pain:
  • Hepatotoxicity (isoniazid, rifampicin, pyrazinamide) → raised ALT/AST, jaundice, RUQ pain
    • If ALT >3x normal with symptoms or >5x normal without symptoms → stop all ATT, reintroduce sequentially once LFTs normalise
  • Gastritis/GI upset (most common) → take drugs with food, use PPIs/antacids

2. Symptomatic Pain Relief

DrugDoseIndication
Antispasmodics (Hyoscine butylbromide/Buscopan)10-20 mg TDS/QDS PO or 20 mg IM/IVColicky pain from intestinal spasm/strictures
Paracetamol500 mg - 1 g TDS-QDSMild-moderate pain; safe with ATT
NSAIDs (Ibuprofen, Diclofenac)With cautionModerate pain; avoid if GI ulceration, poor nutrition, renal impairment
Proton pump inhibitor (Pantoprazole/Omeprazole)40 mg ODGI protection, especially if on NSAIDs or with dyspepsia from ATT
Opioids (Tramadol, Morphine)As requiredSevere pain; short-term; avoid in obstruction unless under surgical care
Avoid NSAIDs in malnourished patients and those with peritoneal involvement due to risk of GI ulceration and masking of perforation.

3. Supportive Measures

  • Nutritional support: High protein, high calorie diet; correct malnutrition (key - poor nutrition impairs healing and drug metabolism)
    • Nasogastric/nasojejunal feeding or TPN if oral intake poor
  • Fluid and electrolyte correction: IV fluids for dehydration
  • Anaemia correction: Iron supplements or transfusion if severe
  • Rest bowel if inflamed: Clear liquids → soft diet as tolerated

4. Adjunctive Corticosteroids

  • Prednisolone may be considered in:
    • Tuberculous peritonitis with tense ascites - reduces inflammation, adhesion formation, and fibrous constriction
    • Severe constitutional symptoms not responding to ATT alone
  • Typical dose: Prednisolone 1 mg/kg/day tapering over 6-8 weeks
  • Use under specialist guidance; evidence is limited but practice is established

B. Subacute / Intermittent Obstruction (On ATT)

Pain is colicky, intermittent, with partial obstruction from strictures.
First - trial of medical management:
  • NBM (nil by mouth) + IV fluids + NGT decompression
  • Continue ATT - strictures from active inflammation may respond within 2 weeks of starting therapy
  • Many cases of obstruction resolve with ATT alone
  • Re-image small bowel after completion of full ATT course
If no response / recurrent episodes → ELECTIVE SURGICAL MANAGEMENT:
ProcedureIndication
StrictureplastySingle short ileal stricture (bowel-conserving)
Limited ileocolic resection + anastomosisTerminal ileal/ileocolic hyperplastic disease
Bowel resectionMultiple closely placed strictures
Right hemicolectomyExtensive ileocolic disease
"The surgical principles are very similar to Crohn's disease - resections should be kept as conservative as possible." - Bailey & Love, 28th Ed.
Post-surgery: continue full course of ATT + nutritional rehabilitation (6-12 months combined physician-surgeon care).

C. Acute Intestinal Obstruction (Emergency)

Pain abdomen + absolute constipation + vomiting + distension.
Pre-operative resuscitation (MANDATORY before theatre):
  1. IV access + vigorous fluid resuscitation (NS or Hartmann's) - correct dehydration and electrolytes
  2. NGT insertion + free drainage - decompress bowel, reduce aspiration risk
  3. Urinary catheter - monitor urine output
  4. Blood transfusion if Hb critically low
  5. Broad-spectrum IV antibiotics: (e.g., Ceftriaxone 1g BD + Metronidazole 500 mg TDS)
  6. Analgesia - IV morphine titrated; do NOT withhold analgesia pending surgery
  7. Correct coagulopathy if present
At Laparotomy - minimum life-saving procedure:
SituationPreferred Operation
Active infection, poor general condition, malnourishedResection of diseased segment + proximal ileostomy + distal mucus fistula (avoids anastomosis - high leak risk)
Good general condition, minimal contaminationResection + primary anastomosis (rare in emergency)
Avoid primary anastomosis in the presence of active infection, severe malnutrition, and poor general condition - anastomotic leak rate is very high. - Bailey & Love, 28th Ed.
Post-operative:
  • Continue/start ATT as soon as bowel function returns
  • Nutritional support (TPN/enteral feeds initially)
  • Plan for stoma reversal + elective disease resection after full course of ATT and when disease is no longer active (normalised inflammatory markers, weight gain, negative cultures)

D. Perforation (Surgical Emergency)

  • Sudden onset severe generalised abdominal pain + peritonism + free gas on AXR/CT
  • Resuscitate aggressively first (ABC, IV fluids, antibiotics, analgesia)
  • Emergency laparotomy:
    • Resection of perforated segment
    • Anastomosis if peritoneal contamination is minimal and patient condition is good
    • Resection + ileostomy if widespread contamination, poor condition, or active disease → restore bowel continuity as second stage after full ATT + nutritional recovery

E. Abdominal Abscess

  • Localised pain, fever, tender mass
  • USS or CT-guided drainage (percutaneous) - first-line if accessible
  • IV antibiotics (broad-spectrum to cover secondary bacterial infection)
  • Continue/optimise ATT
  • Surgical drainage if percutaneous approach fails or abscess not accessible

F. ATT-Induced Hepatotoxicity as Cause of Pain (RUQ/Epigastric)

  • Isoniazid, rifampicin, pyrazinamide are all hepatotoxic
  • Check LFTs urgently
  • If hepatotoxicity confirmed → stop offending ATT drugs, manage liver, restart sequentially

Summary Algorithm

K/C Abdominal Koch's + Pain Abdomen
              ↓
    Emergency signs? (Guarding, Rigidity,
    Free gas, Obstruction, Haemodynamic instability)
         ↓                        ↓
        YES                       NO
         ↓                        ↓
  Resuscitate (IVF,         Is patient on ATT?
  NGT, catheter,                  ↓
  antibiotics, analgesia)    YES → Check:
         ↓                  1. ATT adequacy/adherence
  CT abdomen                2. LFTs (hepatotoxicity)
         ↓                  3. Drug sensitivities (MDR)
  Obstruction?  Perforation?       ↓
      ↓              ↓        Optimise ATT
  Resection +   Resection +   + Symptomatic pain relief
  Ileostomy     ±Anastomosis  (Antispasmodics,
  (or           or Ileostomy  Paracetamol, PPI)
  anastomosis                 + Nutrition support
  if fit)                     + Steroids if peritoneal TB
                                    ↓
                            Subacute obstruction on ATT?
                              → NBM + IV fluids + NGT
                              → Re-image post-ATT
                              → Elective surgery if persists
                              (Strictureplasty / Resection)

Key Principles (Summary Box)

  • ATT is the primary treatment - surgical intervention is reserved for complications
  • Pain relief should not be withheld - analgesia + antispasmodics are appropriate
  • Patients should be under combined physician-surgeon care throughout
  • Vigorous supportive care (nutrition, hydration, anaemia) is mandatory in all cases
  • Obstruction may respond to ATT alone - always give medical therapy first
  • In the emergency setting, do the minimum life-saving procedure - avoid anastomosis in active disease
  • After any surgery, complete the full ATT course before considering further elective procedures
Sources: Bailey & Love's Short Practice of Surgery, 28th Ed.; Sleisenger & Fordtran's GI and Liver Disease; Harrison's Principles of Internal Medicine, 22E; Goldman-Cecil Medicine

Continous loose stools since 7 days with normal CBC management

Finding Sources
Finding Sources
Searching PubMed

"persistent diarrhea" AND management

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
I now have comprehensive data. Here is the complete, clinically structured answer:

Continuous Loose Stools × 7 Days with Normal CBC - Management


Clinical Interpretation of the Findings

7 days = Persistent diarrhoea (acute = <14 days; persistent = 14 days to 4 weeks; chronic = >4 weeks - though many classify >7 days as beyond simple acute gastroenteritis and requiring further workup)
Normal CBC significance:
  • No leucocytosis → argues against invasive bacterial infection (Shigella, Salmonella, Campylobacter), severe colitis, or significant systemic inflammation
  • No anaemia → no significant GI blood loss, malabsorption not yet severe
  • No eosinophilia → makes parasitic infection (helminths) less likely (though not excluded)
  • Strongly suggests: Viral gastroenteritis (prolonged/post-infectious), protozoal infection (Giardia, Cryptosporidium), functional/osmotic causes, or non-invasive bacterial toxin-mediated illness

Step 1 - Assess Severity First

Signs requiring urgent admission / IV management:

FeatureConcern
Sunken eyes, dry mucosa, skin turgor reducedModerate-severe dehydration
HR >100, BP drop, oliguria/anuriaHaemodynamic compromise
High fever (>39°C)Invasive infection despite normal CBC
Bloody/mucoid stoolsInvasive pathogen, IBD flare
Persistent vomiting preventing ORSIV rehydration needed
Age extremes (infant/elderly)Higher risk of rapid deterioration
Immunocompromised, pregnantHigher risk

Step 2 - Further Investigations Needed (7 days, not resolved)

Even with normal CBC, the following are indicated at 7 days:
InvestigationReason
Stool microscopy (wet mount)Giardia cysts/trophozoites, Entamoeba, Cryptosporidium oocysts
Stool R/E (routine/examination)Ova, cysts, parasites, RBCs, pus cells, fat globules
Stool culture and sensitivityPersistent bacterial cause (Salmonella, Campylobacter)
Stool for C. difficile toxinIf recent antibiotics use
Giardia stool antigen / ELISAMore sensitive than microscopy (~90% sensitivity)
Serum electrolytes (Na, K, Cl, HCO3)Electrolyte depletion from prolonged diarrhoea
Blood glucose, urea, creatinineDehydration assessment
Serum albuminNutritional status / protein-losing enteropathy
Stool for reducing substancesIf lactose intolerance suspected (especially post-viral)
Thyroid function (TSH)If chronic/secretory pattern - hyperthyroidism

Step 3 - Likely Causes at 7 Days with Normal CBC

CategoryDiagnosisKey Clues
Protozoal (most important)Giardia lambliaFoul-smelling, greasy, frothy stools; bloating; no blood; contaminated water history
ProtozoalCryptosporidiumWatery diarrhoea; immunocompromised patients particularly at risk
ProtozoalEntamoeba histolyticaDysentery + RLQ pain (but may be non-bloody early); travel history
Post-viralPost-infectious/prolonged viral gastroenteritisNausea, preceded by vomiting; community exposure; Norovirus, Rotavirus
Post-infectiousSecondary lactose intoleranceBloating, gas, watery loose stools after viral GE; worse with dairy
Bacterial (non-invasive)ETEC, Clostridium perfringensWatery, no blood, no fever; food history
Drug-inducedAntibiotic-associated diarrhoea / C. difficileRecent antibiotics in last 8 weeks
OsmoticDietary (sorbitol, fructose, artificial sweeteners)Worse with specific foods; improves with fasting
FunctionalPost-infectious IBSAltered motility after GI infection; normal all investigations
Inflammatory (less likely with normal CBC)IBD (Crohn's/UC early)Recurrent episodes, blood/mucus, weight loss - normal CBC does not exclude

Step 4 - Management

A. REHYDRATION - Most Important Treatment

Oral Rehydration Therapy (ORT) - First line in all cases
WHO ORS formula: Na 75 mEq/L + K 20 mEq/L + Cl 65 mEq/L + Citrate 10 mEq/L + Glucose 75 mEq/L
PreparationDetails
ORS sachets (WHO/UNICEF standard)Dissolve 1 sachet in 1 litre of clean water
Home ORS½ tsp salt + 6 level tsp sugar in 1 litre clean water
Commercial ORSElectral, Pedialyte, Enerzal etc.
Avoid: High-sugar drinks (fruit juices, soft drinks, sports drinks) - worsen fluid loss due to osmotic effect
IV fluid (if ORS cannot be tolerated or severe dehydration):
  • Ringer's Lactate or Normal Saline bolus
  • Replenish Na, K particularly
  • Transition to ORS as soon as tolerated
Zinc supplementation:
  • Children: Zinc sulfate 10-20 mg/day × 10-14 days - reduces severity, duration, and recurrence of diarrhoea
  • Adults: 20 mg/day may be beneficial especially in malnourished patients

B. DIET - BRAT / Low-residue Diet

RecommendedAvoid
Bananas, rice, applesauce, toast (BRAT diet)Dairy products (if secondary lactose intolerance)
Boiled potatoes, dal, khichdiFatty/fried foods
Oral fluids (coconut water, ORS, clear soups)Raw vegetables, spicy food
Soft, easily digestible foodsAlcohol, caffeine
Continue breastfeeding in infantsFruit juices with high osmolality

C. SYMPTOMATIC / ANTI-DIARRHOEAL DRUGS

Use only if no fever, no blood/mucus in stool:
DrugDoseNotes
Loperamide (Imodium)4 mg initially, then 2 mg after each loose stool; max 16 mg/dayReduces motility; do NOT use with fever, bloody stools (risk of toxic megacolon, HUS)
Bismuth subsalicylate524 mg every 30-60 min, max 8 doses/dayAntimicrobial + anti-secretory; safe in most
Racecadotril (Acetorphan)1.5 mg/kg TDS (children); 100 mg TDS (adults)Enkephalinase inhibitor; reduces secretion; safer than loperamide (no motility effect)
Smectite (Diosmectite)3 g TDS in waterBinds toxins/pathogens; safe in all ages; no systemic absorption
- Goldman-Cecil Medicine; Washington Manual of Medical Therapeutics

D. SPECIFIC TREATMENT BASED ON LIKELY CAUSE

Giardiasis (Most likely protozoal cause after 7 days)

DrugDoseDuration
Tinidazole (first line - single dose preferred)2 g PO single dose1 day
Metronidazole400-500 mg TDS PO5-7 days
Nitazoxanide500 mg BD PO3 days
"Treatment is not always successful regardless of drug used, and repeat courses may be necessary." - Tintinalli's Emergency Medicine

Entamoeba histolytica (Amoebiasis)

DrugDoseDuration
Metronidazole (tissue amoebicide)400-800 mg TDS PO5-10 days
Diloxanide furoate (luminal amoebicide - eradicate cysts)500 mg TDS PO10 days
Give both drugs sequentially for complete cure

Cryptosporidiosis

  • Usually self-limiting in immunocompetent
  • Nitazoxanide 500 mg BD × 3 days if prolonged
  • Immunocompromised: treat HIV/immunodeficiency; nitazoxanide

Post-viral / Secondary Lactose Intolerance

  • Lactose-free diet for 2-4 weeks
  • Resume dairy gradually after resolution

Post-infectious IBS / Functional

  • Reassurance + dietary modification
  • Antispasmodics: Mebeverine 135 mg TDS or Hyoscine 10-20 mg TDS
  • Probiotics: Lactobacillus, Saccharomyces boulardii - may reduce duration and recurrence

Antibiotic-associated / C. difficile

  • Stop offending antibiotic
  • Mild-moderate: Oral vancomycin 125 mg QDS × 10 days or Fidaxomicin 200 mg BD × 10 days
  • Metronidazole 400 mg TDS × 10-14 days (if vancomycin unavailable - less effective)
  • FMT (faecal microbiota transplant) for recurrent cases

E. EMPIRICAL ANTIBIOTICS

Indicated in 7-day diarrhoea if:
  • Fever (>38.5°C) + moderate-severe illness
  • Bloody/mucoid stools
  • Traveller's diarrhoea
  • Signs of systemic sepsis
  • Immunocompromised patient
DrugDoseDurationUsed For
Azithromycin500 mg OD PO3 days (1 g single dose for traveller's diarrhoea)Campylobacter, Shigella, ETEC, traveller's diarrhoea (first-line)
Ciprofloxacin500 mg BD PO3-5 daysShigella, ETEC, Salmonella (severe), Vibrio
Rifaximin200 mg TDS PO3 daysNon-invasive traveller's diarrhoea; gut-limited, minimal systemic absorption
Metronidazole400 mg TDS PO5-7 daysGiardia, Amoeba, C. difficile
Avoid antibiotics if STEC (E. coli O157:H7) suspected (bloody diarrhoea + low-grade fever + recent undercooked beef exposure) - antibiotics increase risk of haemolytic uraemic syndrome (HUS) - Goldman-Cecil Medicine; Washington Manual

F. PROBIOTICS

  • Saccharomyces boulardii 250-500 mg BD - reduces duration and recurrence
  • Lactobacillus rhamnosus GG (LGG) - evidence in children and post-antibiotic diarrhoea
  • Useful as adjunct; not a substitute for specific therapy
  • Note: Goldman-Cecil states "probiotics are not useful as treatment" for acute infectious diarrhoea - but post-infectious/antibiotic-associated benefit is established

Summary Treatment Protocol

7 days loose stools + Normal CBC
           ↓
    Assess dehydration
           ↓
    Mild-Moderate              Severe
    ORS + Diet                 IV NS/RL + ORS
    Zinc supplementation       Electrolyte correction
           ↓
    Send: Stool R/E + C&S, Giardia Ag, Serum electrolytes
           ↓
    Symptomatic (no fever, no blood):
    Loperamide OR Racecadotril + Smectite
           ↓
    Empirical specific treatment:
    Likely Giardia → Tinidazole 2g single dose
    Likely Amoeba  → Metronidazole + Diloxanide
    Systemic features → Azithromycin or Ciprofloxacin
           ↓
    Review stool results → Targeted therapy
           ↓
    Not improving at 2 weeks?
    → Refer gastroenterology
    → Consider colonoscopy (IBD, microscopic colitis)
    → Lactose breath test, thyroid function

Key Points

  • Normal CBC does not exclude Giardia, Cryptosporidium, or post-viral causes - these are the most likely diagnoses at 7 days with normal CBC
  • Rehydration is the most important treatment regardless of cause
  • Loperamide is contraindicated if fever or blood in stool - risk of toxic megacolon
  • Tinidazole 2g single dose is the easiest, most effective treatment for Giardia
  • Antibiotics are NOT routinely indicated with normal CBC and no systemic features - most will resolve with ORS + targeted anti-protozoal therapy
  • If not improving by 14 days → gastroenterology referral for colonoscopy to exclude IBD, microscopic colitis
Sources: Washington Manual of Medical Therapeutics; Goldman-Cecil Medicine; Rosen's Emergency Medicine; Sleisenger & Fordtran's GI and Liver Disease; Tintinalli's Emergency Medicine
This is a shared conversation. Sign in to Orris to start your own chat.